351. (Journal Article): Verona Diabetes Study. Diabetes duration and cause-specific mortality in the Verona Diabetes Study.

Brun E, Nelson RG, Bennett PH, Imperatore G, Zoppini G, Verlato G, Muggeo M

352. (Journal Article): ALDH2/ADH2 Polymorphism Associated with Vasculopathy and Neuropathy in Type 2 Diabetes

Suzuki Y, Taniyama M, Muramatsu T, Higuchi S, Ohta S, Atsumi Y, Matsuoka K
 
ABSTRACT: In the history of diabetes, chlorpropamide alcohol flushing test (CPAF) was a big topic in the 1970s to 1980s. Alcohol tolerance after chlorpropamide has prognostic significance, w...

353. (Journal Article): Influence of glucagon-like peptide 1 on fasting glycemia in type 2 diabetic patients treated with insulin after sulfonylurea secondary failure.

Nauck MA, Sauerwald A, Ritzel R, Holst JJ, Schmiegel W
 
ABSTRACT: OBJECTIVE: Glucagon-like peptide 1 (GLP-1) has glucose-dependent insulinotropic and glucagonostatic actions in type 2 diabetic patients on diet and on oral agents. It is not known,...

354. (Journal Article): A recombinant human glucagon-like peptide (GLP)-1-albumin protein (albugon) mimics peptidergic activation of GLP-1 receptor-dependent pathways coupled with satiety, gastrointestinal motility, and glucose homeostasis.

Baggio LL, Huang Q, Brown TJ, Drucker DJ
 
ABSTRACT: Peptide hormones exert unique actions via specific G protein-coupled receptors; however, the therapeutic potential of regulatory peptides is frequently compromised by rapid enzymat...

355. (Journal Article): Synthetic exendin-4 (exenatide) significantly re-duces postprandial and fasting plasma glucose in subjects with type 2 diabetes.

Kolterman OG, Buse JB, Fineman MS, Gaines E, Heintz S, Bicsak TA, Taylor K, Kim D, Aisporna M, Wang Y, Baron AD
 
ABSTRACT: Despite the advent of new treatments, glucose control in the type 2 diabetes population is unsatisfactory. AC2993 (synthetic exendin-4; exenatide), a novel glucose-dependent insuli...

356. (Journal Article): Development and characterization of a glucagon-like peptide 1-albumin conju-gate: the ability to activate the glucagon-like peptide 1 receptor in vivo.

Kim JG, Baggio LL, Bridon DP, Castaigne JP, Robitaille MF, Jette L, Benquet C, Drucker DJ
 
ABSTRACT: The rapid degradation of native glucagon-like peptide 1 (GLP-1) by dipeptidyl peptidase-IV (DPP-IV) has fostered new approaches for generation of degradation-resistant GLP-1 analog...

357. (Journal Article): Lens fluorescence and metabolic control in type 1 diabetic patients: a 14 year follow up study

Kessel L, Sander B, Dalgaard P, Larsen M
 
ABSTRACT: BACKGROUND/AIMS: In this prospective study the authors followed the post-translational modification of the proteins of the lens of the eye by fluorometry over a period of 14 years ...

358. (Journal Article): Diabetes 2001 Vital Statistics.

American Diabetes Association

359. (Journal Article): The effect of intensive diabetes treatment on the development and progression of long-term complications in insulin dependent diabetes mellitus: The diabetes control and com-plications trial.

The Diabetes Control and Complications Trial Research Group

360. (Journal Article): Islet Amyloid, Metabolic Syndrome, and the Natural Progressive History of Type 2 Diabetes Mellitus

Hayden MR
 
ABSTRACT: The presence of amyloid within the islet of the pancreas may be one of the best kept secrets in clinical medicine and translation of this century old finding may help to better und...